Commure
Commure sells AI scribe, RCM, and workflow software to hospitals across many EHR systems.
On the record
Checkpoint: Expected ruling in Adaptamed trade-secret lawsuit against Commure
The call
Commure has scale and cash, but Epic's native AI features and unresolved lawsuits leave its scribe business exposed.
Commure makes software that listens to doctor-patient conversations and writes medical notes automatically, saving doctors time. The problem is that Epic, which runs the computer systems at most big hospitals, just built the same feature into their own system in early 2026, and they partnered with a rival company called Abridge instead of Commure. Commure also faces two lawsuits over stolen trade secrets and has stopped growing its team. The biggest question is whether Epic will keep adding more AI features and keep leaving Commure out in the cold, which would make Commure's business much harder to defend.
Why
01
AI pressure: Epic's native ambient-AI charting and Microsoft/Nuance DAX. Epic now ships its own AI scribe and picked Abridge as partner, squeezing Commure's flagship product from two sides at once. Could AI do the core job? Only partly.
02
Bigger players: Epic Systems. Epic holds about 38% of US hospitals and can bundle scribe and RCM features for free, leaving Commure unpartnered so far. Could a giant copy it? Yes, easily.
03
What protects it. Deep integrations across 60+ EHRs and 500+ hospital sites give Commure reach Epic alone can't replicate, if it holds.
What would change this call
Whether Epic announces a Commure partnership or leaves it unpartnered while expanding native AI charting. Shows whether Epic is co-opting or bypassing Commure as it did with Abridge.
Ruling in the Adaptamed trade-secret lawsuit, expected within 6 to 12 months. Would reveal whether Commure faces material damages or an expanded injunction.
Whether any anchor customer like HCA, Tenet, Providence, or the VA migrates scribe or RCM work to Epic-native tools. Would show direct customer loss to the incumbent EHR.
Ruling in the Adaptamed trade-secret lawsuit, expected within 6 to 12 months. Would reveal whether Commure faces material damages or an expanded injunction.
Whether any anchor customer like HCA, Tenet, Providence, or the VA migrates scribe or RCM work to Epic-native tools. Would show direct customer loss to the incumbent EHR.
Key numbers
- $7B valuation after $70M raise
- Scribe accuracy 93.3% vs Abridge 95.3%, DeepScribe 98.8%
- ~$105M ARR, 150% YoY growth reported
Named risks
- Epic native ambient AI charting and Abridge partnership commoditizing Commure's flagship scribe product.
- Active trade secret lawsuits: Canopy Works injunction (May 2025) and Adaptamed suit (April 2026).
- Kirkland & Ellis disqualification motion in Adaptamed case could disrupt Commure's legal defense and investor relations.
- Flat to declining headcount with negative employee sentiment amid repeated M&A integrations.
- Heavy reliance on vendor-reported metrics with limited independent verification of ARR and automation claims.
Rivals, as read in July 2026
| Rival | Direction | Evidence |
|---|---|---|
| Epic Systems | losing to | Epic shipped native ambient AI charting ~Feb 2026, bundling threat to Commure Scribe |
| Abridge | losing to | Abridge scored 95.3 vs Commure's 93.3 on 2025 KLAS accuracy and has Epic revenue-share tie |
| DeepScribe | losing to | DeepScribe led 2025 KLAS accuracy at 98.8 vs Commure's 93.3 |
| Nuance/Microsoft DAX | losing to | Reported over 50% share of clinical speech recognition market, Azure-integrated as of 2026 |
| Oracle Health and athenahealth | contesting | Both building native ambient AI features that could commoditize Commure's point solutions, 2026 |
Questions people ask
- Is Commure profitable in 2026?
- Commure has not disclosed profitability. Third party researcher Sacra estimated ARR at about $105M in March 2024 with 150% YoY growth, and Commure self-reported ARR doubling three straight years through June 2025, but as a private company it discloses no net income figures.
- Could Epic replace Commure's AI scribe product?
- Epic shipped native ambient AI charting around February 2026 and has an equity or revenue-share arrangement with rival scribe maker Abridge as of 2025, directly threatening Commure's standalone Commure Scribe product, which Commure has not paired with an equivalent Epic partnership.
- Who owns Commure?
- Commure is private, incubated by General Catalyst. CEO Tanay Tandon co-founded Athelas, which merged with Commure in October 2023, and General Catalyst CEO Hemant Taneja serves as Executive Chair. It raised $70M at a $7B valuation on May 19, 2026, led by General Catalyst.
- Is Commure facing any lawsuits?
- Yes. A federal court granted Canopy Works a preliminary injunction against Commure in May 2025 over Strongline Pro trade secrets, and Adaptamed LLC filed a separate trade secret suit on April 20, 2026 alleging Commure used customer credentials to build a competing EHR product.
- Who is Commure's biggest competitor?
- Abridge is the closest direct rival in ambient clinical documentation and holds a reported equity or revenue-share tie with Epic as of 2025, while Epic Systems itself, holding about 38% of US hospital market share in 2023, poses the larger structural threat by bundling native AI charting.
- How much is Commure worth?
- Commure was valued at $7B post-money after raising $70M on May 19, 2026, led by General Catalyst with Sequoia, Morgan Stanley, and Kirkland & Ellis participating, up from a $6B valuation at its October 2023 merger with Athelas.
Timeline
- 2026-06-30Commure Orchestrator referral management platform reaches general availability
- 2026-05-19Commure raises $70M at $7B valuation led by General Catalyst
- 2026-05-07Willis Knighton Health names Commure enterprise Ambient AI partner
- 2026-04-20Adaptamed LLC files trade secret lawsuit against Commure
- 2025-06-19Commure raises $200M growth financing from General Catalyst's CVF
- 2025-05Court grants preliminary injunction against Commure in Canopy Works case
- 2024-12-20Commure acquires Memora Health digital care navigation platform
- 2024-07-16Commure agrees to acquire Augmedix for about $139M
- 2023-10-04Athelas and Commure merge into $6B combined healthcare infrastructure company
Revision history
22 July 2026
First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources
- Best AI Medical Scribe Tools (2026) (2026-06-15)
- Commure at $105M ARR (2024-11-26)
- Abridge vs Ambience vs Freed (2025-07-21)
- Best AI Medical Scribes 2026 (2026-07-11)
- Goodwin's IP Litigation Team Secures Preliminary Injunction (2026-07-07)
- Adaptamed's Lawsuit Claims Competing Software Company Stole Trade Secrets (2026-06-04)
- Kirkland Should Be DQed Over Conflicts (2026-05-18)
- Commure Raises $70M at $7B Valuation (2026-05-19)
- Commure revenue, valuation & funding (2026-04-29)
- Commure Combines with Athelas (2023-10-04)
- Commure and Athelas sign deal to acquire Augmedix (2026-07-08)
- Commure Acquires Memora Health (2024-12-20)